Introduction
Osteopontin, first isolated from rat osteosarcoma, is a noncollagenous phosphoprotein constituting the extracellular matrix (5). Subsequently, osteopontin expression in various tissues including the bone matrix, kidney, placenta, and blood vessel has been reported. Osteopontin is only sporadically expressed in the normal central nervous system, its expression is upregulated after infarction is experimentally produced by middle cerebral artery occlusion (1) (7). Cells expressing osteopontin in the central nervous system are macrophages (1) (7) and microglia (1) .
Although there is similarity in the pathological processes between the cerebral cortex infarction and spinal cord contusion models, some differences are found. Schnell et al. reported that inflammatory responses in the spinal cord are significantly faster and stronger than those in the brain (6). These pathological differences imply that the features of osteopontin expression after spinal cord contusion are not equal to those after brain infarction. We therefore examined temporal and spatial changes of osteopontin mRNA and protein using a rat spinal cord contusion model.
Materials and Methods
All animals were treated and cared for in accordance with the Chiba University School of Medicine guidelines pertaining to the treatment of experimental animals.
8-week-old male Wistar rats were deeply anesthetized with halothane inhaled to 1.2% in 0.5 l/min oxygen. Spinal cord injury was produced by extradural compression using a 30 g rod (3.2 mm in diameter) for 5 min as previously described (2) (4). The animals were allowed to survive for 12 h, 24 h, 3, 7, and 14 days postoperatively. For histological evaluation, after transcardial perfusion with 4% paraformaldehyde under pentobarbital anesthesia, paraffin embedded cross sections were prepared. For northern blot analysis, total RNA was extracted using a Trizol reagent (Gibco) as previously described (3). samples (10 µg/lane) were subjected to formaldehyde-agarose slab gel electrophoresis and transferred to Hybond XL membranes (Amersham). Osteopontin cDNA was labeled with [ α-
32 P] dCTP (Amersham), using a Readiprime random-priming DNA labeling kit (Amersham). Relative values of the density of each band were estimated by NIH Image analysis software on the basis of the control value. RNA probes for in situ hybridization were transcribed in vitro using a DIG RNA labeling mixture (Roche) and performed as described previously with the some modifications before hybridization (2) (3). For immunohistochemistry of osteopontin and astrocyte, sections were stained with anti-osteopontin rabbit polyclonal antibody (LSL) and GFAP monoclonal antibody (Sigma). Tomato-lectin (Sigma) histochemistry were available for staining micloglia. Osteopontin and microglia were double labeled by Alexa Fluor 350-conjugated goat anti-rabbit IgG antibody (Molecular probes) and Texas Red-conjugated avidin D (Vector). Osteopontin, microglia and astrocytes were triple labeled by adding Alexa Fluor 488-conjugated goat anti-mouse IgG antibody (Molecular probes).
Results
In Northern blot analysis, Levels of osteopontin mRNA increased from 24 h, and 3 d after contusion the level reached a peak that was 7 times higher than the normal spinal cord level (P < 0.05).
In in situ hybridization, The number of osteopontin-positive cells increased with time, and reached a peak at 3 days. Osteopontin-positive cells were small round cells, existing mainly in the dorsal part of the spinal cord, where the contusion was made (Fig. A) . We clarified the cell type of osteopontin-expressing cells, using tomato lectin as a marker for microglia. Three days after contusion, tomato lectin-positive microglia were an active state showing the small, round and ameboid morphology (Fig. B) . The distribution of osteopontin mRNA expression coincided partly with that of tomato lectin reactivity in serial sections, indicating that osteopontin-expressing cells were activated microglia.
Immunohistochemistry of osteopontin was seen in the circumference of small round cells, and its intensity reached a maximum level at 3 days. At 3 days, osteopontin was seen in the extracellular matrix, as if they were secreted. Double fluorescent labeling of osteopontinimmunopositive cells and microglia showed that osteopontin immunoreactivity was colocalized with tomato-lectin reactivity at 3 days, suggesting that osteopontin-expressing cells we re activated microglia with small, round and amoeboid morphology. Immunohistochemistry of GFAP -astrocytes and triple labeling of osteopontin, astrocyte and microglia showed GFAP -positive astrocyte located around osteopontin-expressing microglia. 
Discussion
The peak of osteopontin mRNA and protein accumulation was observed also at 3 days after spinal cord injury. The peak of osteopontin mRNA expression in the spinal cord injury model preceded that in the middle cerebral artery occlusion model. The difference in the peak times of osteopontin expression between the two models is likely due to a difference in the inflammatory reaction process. The acute inflammatory response to traumatic injury is significantly faster and stronger in the spinal cord than in the cerebral cortex (6).
Although active microglia expressing osteopontin mRNA were identified in the posterior area of the posterior horn and circumference of the spinal cord, only low expression was observed in microglia in the central area of the spinal cord. These two groups of microglia were equally stained with tomato-lectin, which indicates that these microglia are active. Thus, not all active microglia express osteopontin mRNA; certain triggers may be required for the expression of osteopontin in active microglia.
Osteopontin protein was detected in the cytoplasm at 3 days and in the extracellular matrix 7 days after injury. We speculated that osteopontin may play a role as a cytokine or as an anchor for phagocytosis after secretion into the extracellular matrix. Triple labeling of osteopontin, astrocyte and microglia showed that osteopontin-positive areas were surrounded by astrocytes, which suggests an influence of osteopontin on GFAP -positive astrocyte located around osteopontinexpressing microglia.
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